Neutrogena Invests in Women’s Health Amid Panettiere Death

Neutrogena issued a condolence-filled statement after Hayden Panettiere’s death, saying they were saddened and that they had made her feel unsupported during a difficult time, stressing that this is not who they want to be. The brand also announced a significant investment in a longstanding women’s health partner to expand access to postpartum support. The backlash traces to Panettiere’s 2015 disclosure of postpartum depression and her claim that Neutrogena invoked a morals clause or did not renew her contract after that public discussion. Her death revived scrutiny and calls for a boycott as clips from interviews and passages from her memoir resurfaced, highlighting how the company handled her postpartum-depression disclosures. Neutrogena’s responses have been portrayed as measured, with outlets outlining the sequence of events and the brand emphasizing respect for Panettiere’s family. Some reports also reference a broader context of financial or stock-market reactions connected to the controversy, while the company frames its actions as a commitment to supporting women’s health going forward.